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Abstract We cloned two L subunits of large-conductance
calcium-activated potassium (BK) channels, hKCNMB3
(BKL1) and hKCNMB4 (BKL4). Profiling mRNA expression
showed that hKCNMB3 expression is enriched in testis and
hKCNMB4 expression is very prominent in brain. We coex-
pressed BK channel K (BKK) and BKL4 subunits in vitro in CHO
cells. We compared BKK/L4 mediated currents with those of
smooth muscle BKK/L1 channels. BKL4 slowed activation
kinetics more significantly, led to a steeper apparent calcium
sensitivity, and shifted the voltage range of BK current activation
to more negative potentials than BKL1. BKK/L4 channels were
not blocked by 100 nM charybdotoxin or iberiotoxin, and were
activated by 17L-estradiol.
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1. Introduction
The large-conductance calcium-activated potassium (BK)
channel is a member of the Shaker-related six transmembrane
domain potassium channel superfamily that is sensitive to
voltage and calcium. BK channels may occur as heterooligo-
meric complexes of poreforming BKK subunits [1,2] and aux-
iliary BKL subunits [3^6]. Association of BKL with BKK sub-
units may confer an increased Ca2 sensitivity, di¡erent
kinetic properties as well as a di¡erent pharmacology to BK
channels. BKK mRNAs are nearly ubiquitously expressed in
line with the detection of BK channels in many di¡erent tis-
sues ranging from smooth muscle and kidney tubules to neu-
rons in the central nervous system [7]. In contrast to BKK
mRNA, the expression of BKL mRNAs appears to be re-
stricted to few speci¢c tissues [3,5,6]. E.g., BKL1 subunits
are predominantly expressed in smooth muscle cells, whereas
BKL2 subunits were mainly detected in endocrine tissue.
However, BKL subunits, that matched the high expression
levels of BKK mRNA in the central nervous system, had
not been cloned.
Recently, it was shown that biochemically puri¢ed BK
channels from brain are tightly associated with a small, as
yet unidenti¢ed 25 kDa protein [8]. Most likely, the small
associated protein represents a novel type of BKL subunit
expressed in neuronal tissue. This observation suggested to
us that like in smooth muscle cells, brain BK channels might
consist of heteromultimeric assemblies containing BKK sub-
units and CNS-speci¢c BKL subunits. Possibly, the CNS BKL
subunits would be related in sequence and structure to the
already known BKL1 and BKL2 subunits. Accordingly, a da-
tabase search for EST clones potentially related to novel BKL
subunits resulted in the cloning of two novel human BKL
subunits (BKL3, KCNMB3 and BKL4, KCNMB4). We ¢nd
that BKL4 mRNA is highly expressed in human brain tissue
and may contribute to BK channel diversity in brain. Com-
parably to BKL1 [9^12], coexpression of BKK subunits with
BKL4 leads to slowed activation kinetics, increased Ca2 sen-
sitivity and an altered pharmacology of BK channels. So far,
BK channel diversity has been attributed to alternative splic-
ing of BKK subunit mRNA [13^17], to heteromeric assembly
with other K-like subunits (slack) [18] and to various post-
translational modi¢cation mechanisms [19^22]. When this
manuscript was in preparation, comparable results were pub-
lished for the cloning of BKL3 and BKL4 subunits and their
expression in the Xenopus oocyte expression system [23].
2. Materials and methods
2.1. Identi¢cation and cloning of KCNMB subunits
The NCBI expressed sequence tag (EST) database was searched
with the TBLASTN algorithm using the protein sequence of
KCNMB1 as a query sequence. Three populations of EST sequences
were identi¢ed and aligned using Lasergene DNAStar software
(GATC, Konstanz, Germany). EST clones were obtained from Re-
search Genetics (Huntsville, USA) and Resource Center of the Ger-
man Human Genome Project (Berlin, Germany) respectively. EST
AI309617 contained the complete open reading frame (ORF) of
KCNMB1 [1]. EST clones AI299145 and AI301175 harbored the
complete ORF of KCNMB2 [5]. EST clones AA761761 and
AA236930 contained the incomplete ORF of KCNMB3. The
KCNMB3 ORF was completed by RACE-PCR using the 5P-RACE
system Version 2.0 (Life Technologies, Karlsruhe, Germany) and
gene-speci¢c primers. As template total RNA of human white matter
was used. The sequence of the ampli¢ed product was used for the
derivation of a primer to clone the putative 5P-end of the gene from
human genomic DNA using Pfu Turbo Polymerase (Stratagene, Hei-
delberg, Germany). The derived KCNMB2 and KCNMB3 sequences
were used as query sequences for further TBLASTN searches of the
EST database. EST clone AA906027 contained an incomplete
KCNMB4 open reading frame. It was completed by screening a com-
mercial human cortex cDNA library (Clontech, Heidelberg, Germany)
via PCR.
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2.2. Determination of tissue expression levels
For hybridization studies, the appropriate probe fragments were
puri¢ed twice on agarose gels and labeled with 32P-dATP using the
Ambion StripEZ DNA Kit (AMS Biotech, Frankfurt, Germany).
Human multiple tissue expression arrays (Clontech, Heidelberg, Ger-
many) were hybridized according to the manufacturer’s instructions
and exposed for 1^14 days on a Fuji PhosphorImager (Raytest, Strau-
benhardt, Germany) and/or autoradiographed. Probe fragments were:
KCNMB1, a 437 bp SmaI/BstXI fragment of AI309617; KCNMB2, a
758 bp AccI/NcoI fragment of AI299145; KCNMB3, a 320 bp PCR
product (sense primer 5P-GGCTTCTCAGTCCTAATGTTC-3P ; anti-
sense primer 5P-GTCCAGAGCACTGTTGAGC-3P) ; KCNMB4, a
430 bp PCR product (sense primer 5P-CAACAGTACTGGAAA-
GATGAG-3P ; antisense primer 5P-TACAGCAGATGGAATACAA-
GC-3P). For comparison, we probed the arrays with a 320 bp PCR
product of the hKCNMA1 gene (sense primer 5P-GATGAGCA-
GCCGTCAACAC-3P ; antisense primer 5P-GCATCACCAGGTTC-
CGGAG-3P).
2.3. Genomic localization of KCNMB4
The GenBank HTGS database was searched with the coding se-
quence of KCNMB4 as a probe. A human BAC clone RPC11^792c16
(Acc. No. AC011612) was identi¢ed, that covered three exons of
KCNMB4 on three di¡erent contigs, enabling us to de¢ne the exon/
intron structure of the gene. Electronic PCR of this clone at NCBI
revealed STS markers on chromosome 12. One STS (A005A38, Acc.
No. G20255) was located 570 bp downstream the KCNMB4 stop
codon on an 8.1 kbp contig. Thus, the KCNMB4 gene was localized
to 12q14.1^15.
2.4. Heterologous expression studies
KCNMB cDNAs were subcloned into pcDNA3 (Invitrogen, Gro-
ningen, The Netherlands) using standard cloning methods. CHO cells
were transiently transfected with pcDNA3-hslo (GenBank1 Acc. No.
U11058 [24]; a kind gift from Dr. F. Hofmann, University of Munich)
with or without KCNMB pcDNA3 constructs using Lipofectamine1
(Life Technologies) as recommended by the manufacturer. An EGFP
pcDNA3 construct was cotransfected to label transfected cells with
EGFP-derived green £uorescence. Data for BKK and BKK/L1 in Fig.
4 were derived from HEK293 cell lines stably transfected with rat
KCNMA and rat KCNMA/KCNMB1, respectively [25].
2.5. Electrophysiological measurements and analysis
Current measurements were performed 12^24 h following transfec-
tion, using either the whole-cell or the inside-out con¢guration of the
patch-clamp technique. Patch pipettes were fabricated from borosili-
cate capillaries using a DMZ puller (Zeitz, Augsburg, Germany) and
had resistances between 2 and 3 M6 in recording solution. In whole-
cell experiments the intracellular solution contained (in mM):
140 KCl, 1 EGTA, varied CaCl2 and 10 HEPES (pH 7.2, KOH).
Free Ca2 concentrations were calculated using the program CALCI-
UM [26] as well as measured with the ratiometric Ca2 indicators
Fura-2 or BTC (Molecular Probes, Leiden, The Netherlands). During
inside-out patch-clamp recordings the bath was perfused with the
intracellular solution. The patch pipette was ¢lled with the external
solution (in mM): 135 NaCl, 5 KCl, 2 MgCl2, 2 CaCl2 and 5 HEPES
(pH 7.4, NaOH). Single-channel recordings in the inside-out con¢g-
uration were performed at isometric potassium concentrations using
(in mM): 140 KCl, 2 MgCl2, 2 CaCl2 and 5 HEPES (pH 7.4, KOH)
as pipette solution. All recordings were made at room temperature
(20^22‡C). Current traces were ampli¢ed using an EPC9 patch-clamp
ampli¢er (HEKA Elektronik, Lambrecht, Germany), sampled at
5 kHz and ¢ltered at 2.9 kHz via a 4-pole low-pass bessel ¢lter.
The program package PULSE+PULSEFIT (HEKA Elektronik) was
used for data acquisition and analysis. Leakage and capacitive cur-
rents were subtracted online using the P/4 subtraction method.
Steady-state activation curves were derived from tail currents after
stepping to the test potentials. Data were ¢t to a Boltzmann function
Fig. 1. Sequence alignment of human BK channel L subunit family. Sequence comparison of open reading frames derived from human BK
channel L subunit genes KCNMB1 to KCNMB4. Sequences were aligned using the GCG software alignment program (Genetics Computer
Group, Madison, WI, USA). Aligned residues are boxed in black for three or more identical amino acid residues. Numbers at right refer to
last amino acid residue in each row. One-letter code denotes amino acids. Dots indicate gaps in the sequence alignment. Putative transmem-
brane-spanning segments TM1 and TM2 are overligned. v= consensus N-glycosylation sites, respective asparagine residues are boxed in gray.
Note, only one consensus glycosylation site is conserved in all four BK channel L subunits. Amino acid residues in the KCNMB1 protein se-
quence that have been implicated in high-a⁄nity binding of ChTX to BK channels [33] are labeled with an asterisk.
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G  Gmax=1 eV3V1=2=slope and then normalized to the maximum
of the ¢t. EXCEL (Microsoft, Redmond, USA) and Igor Pro (Wave-
Metrics Inc., Lake Oswego, USA) were used for calculations and
presentation of the data. Data are displayed as means þ S.E.M.
3. Results
3.1. Cloning of KCNMB3 and KCNMB4
A BLAST search in the NCBI-EST database identi¢ed sev-
eral EST sequences which encoded novel BKL subunit sequen-
ces. Alignment with the known KCNMB1 [1,2] and
KCNMB2 [5,6] sequences showed that the novel sequences
represented KCNMB3 and, respectively, KCNMB4 in agree-
ment with recent reports [23,27]. The EST clones were used as
probes to clone the complete open reading frames (ORFs) of
KCNMB3 (BKL3) and KCNMB4 (BKL4). The two genes are
localized to di¡erent chromosomal loci. The KCNMB3 se-
quence was previously mapped to a region of the human
chromosome that is duplicated in the dup (3a) syndrome
[27]. The KCNMB4 gene was localized to chromosome
12q14.1^12q15 by electronic PCR, which identi¢ed the STS
marker A005A38 near the 3P-end of the last exon in the
KCNMB4 ORF (see Section 2).
A sequence alignment of the BKL subunit family is shown
in Fig. 1. Sequences between family members are only mod-
erately conserved (21^43% identical residues). However, the
Fig. 2. Expression pro¢les of BK channel K and L subunits in human tissue. Multiple tissue expression arrays (MTE1, Clontech, Heidelberg,
Germany) were hybridized with 32P-labeled cDNA probes speci¢c for BK channel L subunits KCNMB1 (A), KCNMB2 (B), KCNMB3 (C),
KCNMB4 (D) and the BK channel K subunit KCNMA1 (E). Hybridization conditions and probes are described in Section 2. Autoradio-
graphic exposure times were in A and D 2 days, B and E 9 days and in C 22 days. F: Arrangement of mRNA samples on multiple tissue ex-
pression arrays displayed in A^E.
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structures show several motifs that have been conserved and
may suggest that they are important for BKL subunit func-
tions. The subunits have two homologous possibly membrane-
spanning domains TM1 and TM2. Most likely, the amino-
and carboxy-termini, which are not conserved, face the cyto-
plasm and the sequence between TM1 and TM2 with its con-
sensus N-glycosylation sites represents an extracellular do-
main. Within this domain a characteristic pattern of four
cysteine residues is recognized. By contrast, the sequence mo-
tif that has been correlated with the high-a⁄nity charybdo-
toxin/iberiotoxin binding site of BK channels [28] has not
been conserved and is absent in BKL3 and BKL4 (labeled
with asterisks in Fig. 1).
3.2. Tissue distribution of BKL mRNA
We used commercial dot blots to compare the expression of
BKL mRNAs in 76 di¡erent human tissues (Fig. 2). The re-
sults indicated that each BKL mRNA had a distinct pattern of
expression. For comparison, we have included in this analysis
BKK mRNA, which is expressed in every human tissue tested
except heart atrium, ventricle and septum (Fig. 2E). Consis-
tent with previous results [10,29] BKL1 mRNA expression
seems to be restricted to smooth muscle tissue, e.g. aorta,
stomach, duodenum, ileum, colon, bladder and uterus (Fig.
2A). BKL2 mRNA was strongly expressed in fetal kidney and
to some extent in cardiac tissue, in pituitary gland, hippocam-
pus and several other brain tissues (Fig. 2B). Of all four BKL
subunits, BKL3 mRNA seems to be least abundant. In case of
the BKL3 probe, relatively long exposure times were necessary
to obtain hybridization signals of comparable intensity (Fig.
2C). By contrast, BKL4 appears to be highly and speci¢cally
expressed in central nervous system tissue including spinal
cord, but not e.g. in pituitary gland and in non-neuronal
tissue (Fig. 2D). The BKL4 mRNA expression pro¢le suggests
that BKL4 may represent a nervous system-speci¢c L subunit
of BK channels. Interestingly, biochemical puri¢cation of BK
channels from brain indicated a BKL subunit of V25 kDa
molecular weight tightly associated with brain BK channel K
subunits [8]. The derived size of BKL4 protein (210 amino
acid residues) is compatible with the notion that BKL4 is a
L subunit of neuronal BK channels. In multiple tissue North-
ern blots we have determined the transcript sizes of BKL1^4
mRNAs (data not shown). In agreement with a previous re-
port [23], BKL4 hybridized strongly to a band of 1.9 kbp and
to two minor bands of 3 kbp and 6.1 kbp in all brain tissues.
3.3. Expression of BKK with BKL4 subunits
Since our hybridization results indicated that BKL4 was
most likely a prominent BKL subunit of neuronal BK chan-
nels, we have concentrated on the coexpression of BKK sub-
units with BKL4 subunits in comparison to that with BKL1
subunits. For this purpose, BKL1 and BKL4 cDNAs were
cloned into pcDNA3 expression vectors (pcDNA3 KCNMB1;
pcDNA3 KCNMB4). They were cotransfected into CHO cells
with pcDNA3-hslo. 12^24 h post-transfection, we recorded
Ca2-activated outward currents from the transfected cells.
Macroscopic currents were characterized using both whole-
cell and inside-out patch-clamp con¢gurations.
Representative current traces mediated by BK channels
with or without L subunits are shown in Fig. 3. They were
evoked at voltage pulses ranging from 380 mV to +100 mV in
0.8 WM internal Ca2. In the absence of BKL subunits, BKK
subunits (Fig. 3A,D) typically gave rise to relative rapidly
activating biphasic outward currents (dfast = 1.2 þ 0.2 ms and
Fig. 3. Currents mediated by BK channels in the absence or presence of L subunits KCNMB1 and KCNMB4 in transfected tissue culture cells.
A^C: Macroscopic currents were elicited in whole-cell patch-clamp experiments by stepping the membrane voltage from a holding potential of
380 mV to depolarized test potentials in +20 mV increments up to +100 mV. Cells were bu¡ered to 0.8 WM Ca2. Duration of test potentials
was 500 ms. Tail currents were measured at +40 mV subsequent to the test potentials. A^C are labeled above the current traces for the sub-
units expressed. D: Voltage dependence of activation kinetics of BKK, BKK/L1, BKK/L4 mediated currents (n = 3^5). For comparison, current
traces elicited with a +80 mV test pulse are normalized to the maximum amplitude.
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dslow = 6.6 þ 2.1 ms at +40 mV, n = 3) [5,9^13,23]. BK currents
were activated at 0.8 WM internal Ca2 by depolarizing test
potentials above 0 mV. The conductance/voltage relation had
a midpoint (V1=2) at +84.7 þ 0.2 mV (Fig. 4A,B). In agreement
with previous results [9^12,23], coexpression of BKK with
BKL1 subunits (Fig. 3B) conferred to BK channels an appar-
ent increased sensitivity to intracellular calcium (Fig. 4A,B).
At comparable intracellular Ca2 concentrations, BK currents
activated at more hyperpolarized membrane potentials giving
rise to a negative shift (vV1=2) in the midpoint of the conduc-
tance/voltage relations by V315 to V330 mV (Fig. 4C).
Also, activation of BK channels is slowed in the presence of
BKL1 (Fig. 3B,D). The slow activation time constant (Fig.
3D) at +40 mV for BKK/L1 was 12.9 þ 0.9 ms (n = 2). Coex-
pression of BKL4 with BKK subunits a¡ected the activation
kinetics of BK currents more pronouncedly (dslow = 29.4 þ 8.8
ms at +40 mV, n = 5) than BKL1 (Fig. 3C,D). Like BKL1,
BKL4 shifted the voltage range of BK current activation to
more negative potentials (Fig. 4A,B). In contrast to BKL1,
however, increasing intracellular calcium concentrations
from 0.8 to 11 WM dramatically enlarged the shift in the
midpoint of the conductance/voltage relations from V320
mV to V360 mV (Fig. 4C). Thus, BKL4 conferred a signi¢-
cantly steeper Ca2 dependence onto the apparent conduc-
tance/voltage relation of BK currents (Fig. 4B,C).
The conductance of single BK channels has been shown to
be V200 pS in various in vitro expression systems [30]. Ex-
posure of BK channels to intracellular Ca2 dramatically in-
creased the open probability of the channels without a¡ecting
single-channel conductance [30^32]. We recorded from inside-
out patches BK channel activity þ Ca2 (Fig. 5). Fig. 5A
shows a representative patch recording, where the inside-out
patch was ¢rst bathed in bu¡er containing 0.8 WM Ca2, then
in Ca2-free bathing solution, followed by an exposure to 11
WM Ca2. As expected for BK channels, channel activity is
very sensitive and proportional to the Ca2 concentration
added to the cytoplasmic side of the BK channels. At free
Ca2 a sporadic, mostly single opening of BK channels was
seen (Fig. 5B). At 0.8 WM Ca2 multiple BK channel openings
were seen and at 11 WM BK channel openings were so fre-
quent that single-channel events could no longer be discerned.
The data clearly show that increasing Ca2 in the bath pro-
foundly increased the open probability of BKK/L4 channels
similar to BKK/L1 [31,32]. Single-channel current/voltage re-
lations were obtained from inside-out patch recordings at
0 and 0.8 WM Ca2, respectively, such as shown in Fig.
5A,B. The results showed (Fig. 5C) that the slope of the
current/voltage relations was linear between +20 mV and
+80 mV. The single-channel conductance derived from the
slope at 0 and at 0.8 WM Ca2 was 223 þ 6 pS (n = 2) and
193 þ 14 pS (n = 2), respectively. Like BKL1 [12], BKL4 did
not signi¢cantly in£uence the single-channel conductance of
BK channels.
3.4. Pharmacology of BKK/L4 channels
BK channels are sensitive to block by nM concentrations of
scorpion toxins like charybdotoxin (ChTX) and iberiotoxin
(IbTX) [24,33]. The sensitivity to scorpion toxin block is in-
creased when BK channels contain L1 subunits [24,33]. IC50
values for block of BKK/L1 channels by ChTX or IbTX are in
Fig. 4. KCNMB4 confers increased Ca2 sensitivity to BK channels. A: Plot of conductance versus voltage relation of BKK subunits alone or
coexpressed with BKL1 or BKL4 subunits. Normalized conductance was measured for each test potential from current amplitude taken 2 ms
after repolarization to tail potentials. Data are displayed as the mean þ S.E.M. (n = 3^7). Recordings were made from inside-out patches bathed
in solutions bu¡ered to various calcium concentrations (in WM): for BKK, 0.8 (a), 1.7 (b), 5.0 (E), 10.0 (F) ; for BKK/L1, 1.0 (a), 2.3 (b),
5.0 (E), 8.3 (F) ; and for BKK/L4, 0.02 (a), 0.35 (b), 0.8 (E), 2.3 (F), 11.0 (O), 19.5 (R). Solid curves show ¢ts of data to a Boltzmann func-
tion G  Gmax l=1 e3V3V1=2zF=RT  and then normalized to the maximum of the ¢t. B: Plot of V1=2 versus log calcium concentration.
BKK (a) expressed alone; BKK expressed in the presence of BKL1 (F) and of BKL4 (8), respectively. C: Calcium dependence of vV1=2 (V1=2
BKK minus V1=2 BKK/L1 or BKK/L4). Values at comparable Ca2 concentrations for BKK were extrapolated from B. Labels as in B.
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the 10 nM range. Typically, bath application of 100 nM toxin
resulted in a complete block of BKK/L1 channels (n = 3). Na-
tive BK channels in smooth muscle tissue have a similar scor-
pion toxin sensitivity consistent with the presence of BKK/L1
channels in this tissue [1,2,34]. BKK/L4 mediated outward
currents were measured at 1 WM intracellular calcium and at
test potentials ranging from 380 mV to +120 mV. We found
that BKK/L4 channels are not blocked by 100 nM ChTX or
IbTX, respectively (n = 3; data not shown). The high expres-
sion level of BKL4 subunits in neuronal tissue is consistent
with the observation that neuronal BK channels may not be
sensitive to ChTX or IbTX [35,36]. Recently, it has been re-
ported that 17L-estradiol acts as a BK channel opener on
BKK/L1 [37]. Apparently, 17L-estradiol binds to an extracel-
lular site on BKK/L1 channels that depends on the presence of
BKL1 subunits. Here, we show that 17L-estradiol may also
activate BKK/L4 channels. They were recorded from outside-
out patches bathed in 0 Ca2 solution (Fig. 6). In the absence
of Ca2 and 17L-estradiol the patches showed very little sin-
gle-channel activity, but as soon as 17L-estradiol was applied
to the bath, single-channel activity markedly increased and
correlated to the concentration of 17L-estradiol added to the
bath. 10 WM estradiol activated BK channel to a similar de-
gree like 1 WM intracellular calcium.
4. Discussion
The biochemical puri¢cation of BK channels from tracheal
smooth muscle showed that they are coassembled from BKK
and BKL1 subunits [2]. The subsequent cloning of BKK and
BKL1 cDNAs [10,38] demonstrated that BKK mRNA is ex-
pressed in many di¡erent mammalian tissues, whereas BKL1
mRNA expression appeared to be restricted mainly to smooth
muscle tissue [29,38]. Our mRNA expression pro¢ling of hu-
man BKK and BKL1 mRNAs is in agreement with the pre-
vious reports. It shows that human BKL1 mRNA expression
occurs predominantly in tissue of smooth muscle origin,
whereas BKK mRNA was detectable in almost all the 70
mRNA samples investigated. The discrepancy between BKK
and BKL1 mRNA expression pro¢les suggested that possibly
the tissues and cells, which do not express BKL1 subunits,
may in fact express related, but distinct BKL subunits. Recent
¢ndings [5,23] and our results show that BKL subunits repre-
Fig. 5. Single-channel characteristics of BKK coexpressed with BKL4. A: Calcium dependence of single-channel activity, recorded in the inside-
out con¢guration at +80 mV. A bath superfusion was used to adjust the calcium concentration. Arrows indicate the completed bath exchange.
B: Single-channel events of BKK/L4 (left) were extracted from the record shown in A, at times indicated by the triangles. Corresponding ampli-
tude histograms of the events (right). C: Single-channel conductance of BKK/L4 at 0 WM Ca2 (a) and 0.8 WM Ca2 (b), respectively. Single-
channel currents were measured by amplitude histogram analysis of two patches for each condition.
Fig. 6. Agonistic e¡ect of 17L-estradiol on BKK/L4 mediated cur-
rents. Depicted are current traces from the same outside-out patch
superfused successively with external solution alone (control) or con-
taining 3 and 10 WM 17L-estradiol, respectively. The patch was held
at 380 mV and currents were recorded after depolarizing voltage
steps of 500 ms duration to +80 mV. Internal solution was practi-
cally free of calcium.
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sent a family of at least four related subunits, which have
distinct expression patterns in human (mammalian) tissue
and also confer distinct gating properties to BKK channels
[5,23]. Here we show that BKL4 is a BK channel subunit,
which is prominently expressed in human brain. Therefore,
BKK/L4 type BK channels may resemble BK channels meas-
ured in neuronal tissue. It has been shown that neuronal BK
channels are not blocked by IbTX and ChTX in contrast to
smooth muscle BK channels [35,36]. Indeed, BKK/L4 channels
could not be blocked by ChTX or IbTX concentrations that
typically blocked BKK/L1 channels [35,36]. These results sup-
port the notion that BKK/L4 channels correlate with channels
as they occur in native neuronal tissue. It has been shown that
certain amino acid residues in the extracellular loop sequence
of BKL1 (see Fig. 1) are involved in the generation of the
high-a⁄nity ChTX binding site of BK channels [33]. Some
of the amino acid residues are mutated in the derived BKL4
protein sequence. It remains to be shown whether these mu-
tations are indeed responsible for the absence of a high toxin
sensitivity of BKK/L4 channels. At low calcium concentra-
tions, the open probability of BKK/L4 channels was signi¢-
cantly increased by extracellular 17L-estradiol like BKK/L1
[37]. Apparently, the extracellular 17L-estradiol binding site
has been conserved between BKK/L1 and BKK/L4 channels.
The results suggest that 17L-estradiol may not only open
smooth muscle BK channels, but also neuronal BK channels.
It will be interesting to see whether BK channel activity in
neurons can be modulated by 17L-estradiol application and
how steroid hormone induced opening of neuronal BK chan-
nels may a¡ect neuronal excitability.
It has been shown that BKL1 subunits increase the open
probability of BK channels [39]. The BKL4 subunits seem to
have a similar e¡ect on BK channels. However, the in£uence
of BKL1 and BKL4 subunits on BK channels appeared not
uniform. BKL4 slowed the gating kinetics of BK channels
more profoundly than BKL1. While this manuscript was in
preparation, a recent report [23] showed that in the Xenopus
oocyte expression system 1 to 10 WM Ca2 concentrations
shifted V1=2 of BKK/L4 current activation to more positive
potentials and Ca2 concentrations of 6 50 WM to negative
potentials. In contrast, the expression of BKK/L4 channels in
CHO cells produced BK currents, whose V1=2 values were
dramatically shifted to negative potentials by 1 to 20 WM
Ca2 concentrations. For example, 10 WM Ca2 shifted
BKK/L4 currents by +7.5 þ 4.9 mV to V1=2W+50 mV in the
Xenopus oocyte expression system [23] and by 360 mV to
V1=2 =356 mV in the CHO expression system. The reasons
for this discrepancy are not clear. Our data show that BKK/L4
currents were shifted by V20 to 360 mV when the Ca2
concentration was raised from 1 to 11 WM. This may indicate
that BKL4 confers an exquisite Ca2 sensitivity onto BK
channels in a physiologically important Ca2 concentration
range. At 10 WM Ca2 BKK/L4 channels may operate in a
more negative voltage range than BKK/L1 channels and,
thereby, signi¢cantly contribute to attenuating neuronal excit-
ability. Note, at very low calcium concentrations (0.02 WM)
we apparently observed a less negative shift in the conduc-
tance/voltage relation of BKK/L4 currents. For experimental
reasons, we did not go to test potentials above +120 mV and,
therefore, could not determine maximum conductance values
at very low calcium concentrations. Instead, the values were
extrapolated from the ¢t of the data to a Boltzmann function.
Therefore, the V1=2 values at very low calcium concentrations
may be an underestimate.
Previously, much of the BK channel diversity in gating
kinetics, apparent voltage dependence and Ca2 sensitivity
in pharmacology have been attributed to alternatively spliced
BKK subunits [13^17] and/or posttranslational modi¢cations
[19^21]. Recent reports [5,6,23] and our results show that
heteromultimerization of BKK subunits with di¡erent BKL
subunits may also make a signi¢cant contribution to BK
channel diversity. The analysis of the tissue expression of
BKL1 to BKL4 mRNAs suggests that speci¢c BKK/L combi-
nations are expressed in di¡erent tissues and have distinct
expression patterns. In conclusion, our results indicate that
smooth muscle and neuronal BK channels may have di¡erent
subunit compositions.
Acknowledgements: O.P. thanks the European Union for generous
support.
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